High basal levels of functional Toll-Like Receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration

Endocrinology

Volumn 148, Issue 9, 2007, Pages 4226-4237

  McCall, Kelly D ^a   Harii, Norikazu ^a   Lewis, Christopher J ^a   Malgor, Ramiro ^a   Won, Bae Kim ^a,d   Saji, Motoyasu ^b   Kohn, Aimee D ^c   Moon, Randall T ^c   Kohn, Leonard D ^a,e  

^a OHIO UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d University of Ulsan College of Medicine   (South Korea)

^e OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE DERIVATIVE; BETA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LUCIFERASE; PHENYLMETHIMAZOLE; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE REPRESSION; MIGRATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THYROID CANCER;

CARCINOMA, PAPILLARY; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; METHIMAZOLE; PROTO-ONCOGENE PROTEINS; THYROID NEOPLASMS; TOLL-LIKE RECEPTOR 3; WNT PROTEINS;

EID: 34548064011     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0459     Document Type: Article

References (79)

1. Segev DL, Umbricht C, Zeiger MA 2003 Molecular pathogenesis of thyroid cancer. Surg Oncol 12:69-90
2. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458-463
3. Cadigan KM, Nusse R 1997 Wnt signaling: a common theme in animal development. Genes Dev 11:3286-3305
4. Peifer M, Polakis P 2000 Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science 287:1606-1609
5. Chan SK, Struhl G 2002 Evidence that Armadillo transduces wingless by mediating nuclear export or cytosolic activation of Pangolin. Cell 111:265-280
6. Bienz M, Clevers H 2003 Armadillo/β-catenin signals in the nucleus: proof beyond a reasonable doubt? Nat Cell Biol 5:179-182
7. Sheldahl LC, Park M, Malbon CC, Moon RT 1999 Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 9:695-698
8. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16:279-283
9. Gavrielides MV, Frijhoff AF, Conti CJ, Kazanietz MG 2004 Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets 5:431-443
10. Iozzo RV, Eichstetter I, Danielson KG 1995 Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55:3495-3499
11. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM 2002 Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1:279-288
12. Saitoh T, Katoh M 2002 Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFα in MKN45 cells and up-regulation of WNT5B by β-estradiol in MCF-7 cells. Int J Mol Med 10:345-349
13. Pham K, Milovanovic T, Barr RJ, Truong T, Holcombe RF 2003 Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features. Mol Pathol 56:280-285
14. Olson DJ, Papkoff J 1994 Regulated expression of Wnt family members during proliferation of C57mg mammary cells. Cell Growth Differ 5:197-206
15. Wong GT, Gavin BJ, McMahon AP 1994 Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol 14:6278-6286
16. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J 1997 Transformation by Wnt family proteins correlates with regulation of β-catenin. Cell Growth Differ 8:1349-1358
17. 2+ pathway to antagonize Wnt/β-catenin signaling. Mol Cell Biol 23:131-139
18. Kohn AD, Moon RT 2005 Wnt and calcium signaling: β-catenin-independent pathways. Cell Calcium 38:439-446
19. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN 2003 Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4:349-360
20. Kremenevskaja N, von Wasielewski R, Rao AS, Schofl C, Andersson T, Brabant G 2005 Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24:2144-2154
21. Harii N, Lewis C, Vasko V, McCall K, Benavides-Peralta U, Sun X, Ringel M, Saji M, Kohn L 2005 Thyrocytes express a functional toll-like receptor 3(TLR3): overexpression can be induced by viral infection, reversed by phenylmethimazole, and is associated with Hashimoto's autoimmune thyroiditis. Mol Endocrinol 19:1231-1250
22. Takeda K, Akira S 2004 Microbial recognition by Toll-like receptors. J Dermatol Sci 34:73-82
23. Underhill DM 2003 Toll-like receptors: networking for success. Eur J Immunol 33:1767-1775
24. Barton GM, Medzhitov R 2003 Toll-like receptor signaling pathways. Science 300:1524-1525
25. Takeda K, Kaisho T, Akira S 2003 Toll-like receptors. Annu Rev Immunol 21:335-376
26. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A 2000 Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164:5998-6004
27. Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA 2005 TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 174:131-142
28. Takeda K, Akira S 2003 Toll receptors and pathogen resistance. Cell Microbiol 5:143-153
29. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T 2003 TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 4:161-167
30. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S 2002 Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J Immunol 169:6668-6672
31. Miettinen M, Sareneva T, Julkunen I, Matikainen S 2001 IFNs activate toll-like receptor gene expression in viral infections. Genes Immun 2:349-355
32. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA 2001 Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732-738
33. Suzuki K, Mori A, Ishii KJ, Saito J, Singer DS, Klinman DM, Krause PR, Kohn LD 1999 Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci USA 96:2285-2290
34. Saikh KU, Lee JS, Kissner TL, Dyas B, Ulrich RG 2003 Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J Infect Dis 188:1562-1570
35. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA 2000 Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA 97:2791-2796
36. Ullmannova V, Stockbauer P, Hradcova M, Soucek J, Haskovec C 2003 Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk Res 27:1115-1123
37. Williams ED 2000 Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8:181-183
38. Johnsen IB, Nguyen TT, Ringdal M, Tryggestad AM, Bakke O, Lien E, Espevik T, Anthonsen MW 2006 Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 25:3335-3346
39. Cheng G, Nazar AS, Shin HS, Vanguri P, Shin ML 1998 IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent kappaB site but not IRF-1 or viral transcription. J Interferon Cytokine Res 18:987-997
40. Majumder S, Zhou LZ, Chaturvedi P, Babcock G, Aras S, Ransohoff RM 1998 Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. J Neurosci Res 54:169-180
41. Ohmori Y, Hamilton TA 1995 The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J Immunol 154:5235-5244
42. Dayan CM, Daniels GH 1996 Chronic autoimmune thyroiditis. N Engl J Med 335:99-107
43. Liu J, Xiang Z, Ma X 2004 Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl- N-nitrosourea-induced T lymphoma. J Immunol 173:1184-1193
44. Dagia NM, Harii N, Meli AE, Sun X, Lewis CJ, Kohn LD, Goetz DJ 2004 Phenyl methimazole inhibits TNF-α-induced VCAM-1 expression in an IFN regulatory factor-1-dependent manner and reduces monocytic cell adhesion to endothelial cells. J Immunol 173:2041-2049
45. Baker MS, Chen X, Rotramel AR, Nelson JJ, Kaufman DB 2003 Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets. Surgery 134:134-141
46. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T 1989 Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739
47. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T 1988 Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54:903-913
48. Heinz S, Haehnel V, Karaghiosoff M, Schwarzfischer L, Muller M, Krause SW, Rehli M 2003 Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 278:21502-21509
49. Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI, Park YM, Oh S, Shin JG, Yao S, Chen L, Choi IH 2006 Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-γ-induced upregulation of B7-H1 (CD274). FEBS Lett 580:755-762
50. Contente S, Attard FA, Yeh TJ, Buchhagen DL, Friedman RM 2003 Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. J Interferon Cytokine Res 23:639-647
51. Rubinstein YR, Proctor KN, Bergel M, Murphy B, Johnson AC 1998 Interferon regulatory factor-1 is a major regulator of epidermal growth factor receptor gene expression. FEBS Lett 431:268-272
52. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M 2003 Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 94:593-597
53. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA 2005 Importance of P-cadherin, β-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 11:8606-8614
54. Fujio Y, Matsuda T, Oshima Y, Maeda M, Mohri T, Ito T, Takatani T, Hirata M, Nakaoka Y, Kimura R, Kishimoto T, Azuma J 2004 Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes. FEBS Lett 573:202-206
55. Suiqing C, Min Z, Lirong C 2005 Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 32:354-360
56. Kortylewski M, Jove R, Yu H 2005 Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev 24:315-327
57. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A 2003 STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197:157-168
58. Kojima H, Sasaki T, Ishitani T, Iemura S, Zhao H, Kaneko S, Kunimoto H, Natsume T, Matsumoto K, Nakajima K 2005 STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFβ-activated kinase 1 for STAT3 Ser-727 phosphorylation. Proc Natl Acad Sci USA 102:4524-4529
59. Shen Y, La Perle KM, Levy DE, Darnell Jr JE 2005 Reduced STAT3 activity in mice mimics clinical disease syndromes. Biochem Biophys Res Commun 330:305-309
60. Gartsbein M, Alt A, Hashimoto K, Nakajima K, Kuroki T, Tennenbaum T 2006 The role of protein kinase Cδ activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation. J Cell Sci 119:470-481
61. Barboza JA, Wang S, Schaefer TS 2004 Generation and characterization of a constitutively active Stat3 protein. Mol Biol Rep 31:13-21
62. Yeh YT, Ou-Yang F, Chen IF, Yang SF, Wang YY, Chuang HY, Su JH, Hou MF, Yuan SS 2006 STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma. Int J Cancer 118:2943-2947
63. Wen Z, Zhong Z, Darnell Jr JE 1995 Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250
64. Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T, Heine H, Brandt E, Reiling N 2006 The Wingless homologue Wnt5a and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108:965-973
65. Zeki K, Spambalg D, Sharifi N, Gonsky R, Fagin JA 1994 Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms. J Clin Endocrinol Metab 79:1317-1321
66. Miyake N, Maeta H, Horie S, Kitamura Y, Nanba E, Kobayashi K, Terada T 2001 Absence of mutations in the β-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas. Pathol Int 51:680-685
67. Kim W, Lewis C, McCall K, Malgor R, Kohn A, Moon R, Kohn L 2007 Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms. J Endocrinol 192:93-106
68. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC 2004 Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11:1060-1067
69. Kumar S, Leontovich A, Coenen MJ, Bahn RS 2005 Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis. J Clin Endocrinol Metab 90:4730-4735
70. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z 2007 Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity. J Biol Chem 282:11221-11229
71. Dhar K, Banerjee S, Dhar G, Sengupta K, Banerjee SK 2007 Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptorpositive breast tumor cells. Cancer Res 67:1520-1526
72. Lee TH, Tai DI, Cheng CJ, Sun CS, Lin CY, Sheu MJ, Lee WP, Peng CY, Wang AH, Tsai SL 2006 Enhanced nuclear factor-κB-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics. J Biomed Sci 13:27-39
73. Nakagiri S, Murakami A, Takada S, Akiyama T, Yonehara S 2005 Viral FLIP enhances Wnt signaling downstream of stabilized β-catenin, leading to control of cell growth. Mol Cell Biol 25:9249-9258
74. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S 2004 The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199:1641-1650
75. Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G 2004 Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 199:1651-1658
76. Ouyang B, Knauf JA, Smith EP, Zhang L, Ramsey T, Yusuff N, Batt D, Fagin JA 2006 Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Clin Cancer Res 12:1785-1793
77. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457
78. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL 1997 Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 107:95-100
79. Russell JP, Shinohara S, Melillo RM, Castellone MD, Santoro M, Rothstein JL 2003 Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. Oncogene 22:4569-4577